U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07243184) titled 'The Feasibility Study of Polymer Artificial Heart Valve for the Treatment the Mitral Valve Disease.' on Nov. 17.
Brief Summary: The study aims to evaluate the feasibility and safety of polymer artificial heart valve designed and developed by Shanghai HeartEpoch Medical technology Co. Ltd. for the treatment of the mitral valve diseases.
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
Mital Valve Disease
Intervention:
DEVICE: mitral valve replacement
device: polymer artificial heart valve mitral valve replacement
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Shanghai HeartEpoch Medical Technology Co., Ltd...